Head-to-Head

Johnson & Johnson vs. Theravance Biopharma, Inc.

JNJ

Johnson & Johnson

$265.77 -1.57%

VS TBPH

Theravance Biopharma, Inc.

$17.04 +0.06%

Johnson & Johnson (JNJ) comes out ahead, leading on 6 of 9 compared factors.

Size & Scale

JNJTBPH
Market Cap $650.67 billion $884.18 million
Revenue (TTM) $97.93 billion $104.31 million
Net Income (TTM) $21.04 billion $53.81 million

JNJ leads on 3 of 3 size & scale factors.

Valuation

JNJTBPH
P/E Ratio 30.83 16.87
Price / Book 7.66 3.05
Price / Sales 6.64 8.48

TBPH leads on 2 of 3 valuation factors.

Profitability

JNJTBPH
Net Margin 21.48% 51.58%
Return on Equity 24.76% 18.57%

JNJ and TBPH split the profitability factors evenly.

Dividend

JNJTBPH
Dividend Yield 2.02% —
Payout Ratio 62.18 —

JNJ and TBPH split the dividend factors evenly.

Risk & Sentiment

JNJTBPH
Short Interest 0.67% 11.71%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: JNJ overview, JNJ financials, TBPH overview, TBPH financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.